FDA Letter API

Only Natural, Inc. dba Bio Nutrition, Inc.

Letter data

Company
Only Natural, Inc. dba Bio Nutrition, Inc.
Recipient
Mr. Steven Myers | President | Only Natural, Inc. dba Bio Nutrition, Inc. | 3055 New Street | Oceanside | , | NY | 11572 | United States
Issue date
2021-07-29
Posted date
Not available
FDA office
Division of Human and Animal Food Operations East I
Subject
Not available
Product
Dietary Supplements
CMS ID
605076
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Only Natural, Inc. dba Bio Nutrition, Inc. MARCS-CMS 605076 — July 29, 2021 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA UNITED PARCEL SERVICE Product: Dietary Supplements Recipient: Recipient Name Mr. Steven Myers Recipient Title President Only Natural, Inc. dba Bio Nutrition, Inc. 3055 New Street Oceanside , NY 11572 United States Issuing Office: Division of Human and Animal Food Operations East I United States Dear Mr. Myers: The Food and Drug Administration has completed evaluation of your firm's corrective actions in response to our Warning Letter CMS# 605076, issued on June 18, 2021. Since issuance of the Warning Letter, there have been changes in the responsible firm operations. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter pertaining to your firm. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections. This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ CDR Catherine Beer Director, Compliance Branch Office of Human and Animal Food Operations East Division 1 Content current as of: 07/30/2021 Regulated Product(s) Dietary Supplements